Histology Series 4: Improving The Reliability of NASH Clinical Trial Outcomes: What Is the Optimal Number of Hepatopathologists and Digital Slides, Pros and Cons

E-mail Print

Materials

Agenda

Presentations

The Intercept Experience
M. Michelle Berrey, Intercept Pharmaceuticals
Arun Sanyal, VCA

Hepatopathologist Survey and Histology Slides
Elizabeth M. Brunt, Washington University School of Medicine in St. Louis

Lessons Learned
Zachary Goodman, Inova Fairfax Hospital

Panel Discussion